TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Integrated muscle protein synthesis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Maximal tolerable dose (MTD)
Endpoint domain: Adverse events/effects
Primary endpoint: Recommended phase II dose (RP2D)
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of Patients With Disease-related Clinical Manifestations During 6 Months Before and 6 Months After Secukinumab Initiation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of Patients With Disease-related Clinical Manifestations During 6 Months Before Secukinumab Introduction Who Experienced Reduced or Eliminated Manifestations During 6 Months of Secukinumab Treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of Patients With Disease-related Clinical Manifestations During 6 Months Before Secukinumab Introduction Who Experienced Increased Clinical Manifestations During 6 Months of Secukinumab Treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Onset of shivering
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mother-Baby Interaction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Safety of Al18F-NOTA-Pentixafor
Endpoint domain: Adverse events/effects
Primary endpoint: Diagnostic accuracy of Al18F-NOTA-Pentixafor PET/CT for PA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Surgical outcomes guided by Al18F-NOTA-Pentixafor PET/CT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in global myocardial flow reserve
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in global native T1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Adverse events (AE) occurrence and incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Objective response rate (ORR) per RECIST v1.1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Modified Rankin Scale (mRS) 0-1 at 90 days
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Concordance rate between patient and oncologist
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Gastroparesis Cardinal Symptom Index Daily Diary
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in Patient Assessment of Upper Gastrointestinal Disorder Symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in Y-BOCS total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cardiovascular reactivity (Pre-Ejection Period - PEP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in alveolar bone width
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of (S)AE and device deficiencies
Endpoint domain: Adverse events/effects
Primary endpoint: Change in bone deposition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change from baseline HgbA1c at 3 months post-visit
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Six-minute walking test (6MWT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Short Form 36 Health Survey Questionnaire (SF-36)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Proportion of participants meeting rescue criterion (serum total T3 > ULN)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Disease-free survival absolute
Endpoint domain: Mortality/survival
Primary endpoint: Number of participants with Celiac disease patterns
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognitive performance - Montreal Cognitive Assessment (MoCA)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Cognitive performance - Phototest
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Cognitive performance - Test of Executive Functions Free from Schooling Bias (TELE)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Socioemotional performance - UCLA Loneliness Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Socioemotional performance - Geriatric Depression Scale (GDS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percentual annual growth of atherosclerotic plaques
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Endometriosis onset risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: All causes of death within 30 days
Endpoint domain: Mortality/survival
Primary endpoint: Wound size reduction or assistance with closure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Headache disability index
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Maximum observed plasma concentration (Cmax) of BMS-986256
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the plasma concentration-time curve from time zero to time of the last quantifiable concentration (AUC(0-T)) of BMS-986256
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the plasma concentration-time curve from time zero extrapolated to infinite time (AUC(INF)) of BMS-986256
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: KATZ Activities of Daily Living Scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Lawton Brody Activities of Daily Living Scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Brief Pain Inventory - Short Form (BPI-SF) Interference score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percentage coefficient of variation of intra-day glucose levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Attentional function
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Goal Achievement Scale (GAS)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Edinburgh postpartum depression scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Patient satisfaction regarding scar change
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Pittsburgh Sleep Quality Survey
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Berlin Survey
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Functional Outcomes of Sleep Scale (FOSQ)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Detection of gastrointestinal motility disorders
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Epicardial adipose tissue volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Levels of H3.1 nucleosomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fibroblasts cell morphology
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fibroblasts migration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: strength of shoulder muscle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Tolerability of Heat Therapy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Response rate (confirmed, complete or partial)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of SARS-CoV-2 infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Number of Servings of Unprocessed and Minimally Processed Fruits and Vegetables
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of Servings of Unprocessed and Minimally Processed Whole Grains
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of Servings of Unprocessed and Minimally Processed Legumes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number Servings of Unprocessed and Minimally Processed Nuts/Seeds
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of bucking and inadequate depth of anesthesia
Endpoint domain: Adverse events/effects
Primary endpoint: Lower limb functionality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in planned clinical management
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference between actual age and symptomatology versus intended use criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Calgary Depression Rating Scale (CDRS) change from baseline
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Positive and Negative Syndrome Scale (PANSS) change from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Columbia Suicide Severity Rating Scale (C-SSRS) change from baseline
Endpoint domain: Adverse events/effects
Primary endpoint: Change from baseline in Hammersmith Functional Motor Scale - Expanded (HFMSE) total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NIH Toolbox
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Multiple Sclerosis Quality of Life (MSQOL)-54 scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in baseline Malondialdehyde (MDA) level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Progression of liver injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Proportion of subjects achieving at least a 75% reduction in Eczema Area and Severity Index (EASI 75)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of subjects achieving Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD) of 0 or 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fluid requirement (number of times needing bolus infusion-during surgery)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Diagnostic CXR Reports
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Capsular contracture rate
Endpoint domain: Adverse events/effects
Primary endpoint: Change From Baseline in Modified Ashworth Scale (MAS) Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time in Range (3.9 to 10.0 mmol/l)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: serum High density lipoprotein cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: serum low density lipoprotein cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of emergency department admissions
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Pain Relief - Numeric Rating Scale (NRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain Relief - Visual Analog Scale (VAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with mild rectal bleeding (grade 0-1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Primary endpoint
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symptom
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional neurologic outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of life score (FACT-L Total Score)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Ramsay Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 10-meter walk test (10mWT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: euploidy rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bladder size
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: FTT uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PARP expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Transplant related mortality rate
Endpoint domain: Mortality/survival
Primary endpoint: Number of individuals with low pink esthetic outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presentation of axillary lymphadenopathy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Exercise completion rate
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Nutrition compliance rate
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Mindfulness compliance rate
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mammary clearance of cimetidine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mammary epithelial cell expression of BCRP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mammary epithelial cell expression of OCT1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in client satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in satisfaction with the information
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Physical Fitness Index (PFI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: correlation between the human aerosolization patterns and the severity of illness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disruptive Behavior Disorders rating scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Impairment Rating Scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Academic Performance Rating Scale
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in International Prostate Symptom Score (IPSS) from baseline to month 3
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in International Prostate Symptom Score (IPSS) from baseline to 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: WHOQOL-BREF-TW score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Evolution of the HIV reservoir
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Immune host responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Clinical itch intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Satisfaction and compassion fatigue
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Attention Mechanism of Depression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: rate of change of IL-6
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: rate of change of β2-MG
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rate of change of PTH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Posterior Femoral Offset
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Posterior Femoral Offset Ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Patients Who Experienced Ocular Anesthesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity and specificity of BioFire FilmArray BCID2 panel
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Rebleeding rate within 72 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neural activity of the medial prefrontal cortex
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Rate of NIV-NAVA failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Fugl-Meyer Upper Extremity (FMA-UE) Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of deaths after naloxone administration
Endpoint domain: Mortality/survival
Primary endpoint: Administration rate of THN
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: intervention delivery
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Children SSQ score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Successful performance of real-time eye tracking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of sleep disorders
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Length of stay in the short-stay geriatric unit
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Change in knowledge, attitudes, and perception towards antibiotics use
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Self-Care Ability Scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Fluid Control Scale in Hemodialysis Patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients discharged on D0
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Number of hours of hospitalization
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Wound Healing Parameters - Vascularity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wound Healing Parameters - Pigmentation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wound Healing Parameters - Thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wound Healing Parameters - Pliability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Trunk neuromuscular control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Spinopelvic and lower limb motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Spinopelvic forces
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Step Time and Cycle Time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Balance (rigid surface)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response to self-reported questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change from Baseline in Columbia Suicide Severity Rating Scale (C-SSRS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of participants with Clinically Significant Clinical Laboratory Parameter Values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: One-year change in pulmonary function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Gut microbiome change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Serious Adverse Events Related to Aortix
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Baseline AKI Stage Compared to AKI Stage at 72 Hours Post-surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Number of Participants Requiring Postoperative Use of Renal Replacement Therapy, Ultrafiltration, and/or Dialysis
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Visual clarity during arthroscopic rotator cuff repair
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent changes in fasting concentrations of high-density lipoprotein cholesterol (HDL-C)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Days At Home Alive at 30 days after surgery
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Incidence of Erythrocytosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Diagnostic Accuracy of the JAKPOT Prediction Rule
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EOCRC Survival Assessed by Geographic Location
Endpoint domain: Mortality/survival
Primary endpoint: Change in functional independence of activity of daily living
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: NPC screening effectiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Immune Safety
Endpoint domain: Adverse events/effects